Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07762170

Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)

Conditions: Back Pain Lower Back, Neck Pain, Radiculopathy Multiple Sites, Spinal Stenosis Cervicothoracic Region, Spinal Stenosis Lumbar, Failed Back Surgery Syndrome (FBSS), Sciatica, Intervertebral Disc Disorders With Radiculopathy, Lumbar Region, Spine Osteoarthritis

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 500
Sponsor: Igor Wilderman. MD

Location: Wilderman Medical Clinic Thornhill Ontario

Summary

This study aims to analyze the efficacy and safety of different kinds of steroid injections for back pain, comparing different steroids, dosages, locations (epidural, facet joints, nerve blocks), and also the difference between injections with steroids and local anesthetics, to optimize this treatment that is currently not standardized. The investigators will compare retrospectively and prospectively the efficacy of different injections in the same patients, using mainly a parameter called integral of pain relief, which combines the percentage of pain relief provided by a treatment and its duration over time, as well as improvements in functionality.

Eligibility Criteria

Inclusion Criteria: * \>18 years of age; * Diagnosis of lumbar, cervical, or thoracic pain with various etiologies; * Eligibility to receive steroid injections for back pain, including epidural, facet joints, or SIJ injections, or other injections (e.g., local anesthetics); * Being willing and able to provide NRS pain ratings and PROMIS functionality ratings before the intervention, and the same scores plus IPR, fIPR, and PGIC at various follow-up points after the intervention; * Provide written informed consent. Exclusion Criteria: * Diagnosis of dementia, Parkinson's disease or other cognitive impairments; * Congenital or acquired polyneuropathy; * Back surgery in the month before injection treatment or planned surgery in the subsequent 3 months; * Any clinically significant acute or chronic medical condition that in the judgment of Investigator may preclude injection in the epidural space or compromise patient safety, limit patient's ability to complete the study, and/or compromise the objectives of the study; * Participation in any other competing clinical study within 3 months prior to screening and during the study period.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07762170). StuddyBuddy aggregates publicly available trial information.